2-Phenyl-2-(l-hydroxycycloalkyl)ethylamine Derivatives: Synthesis and Antidepressant Activity

Journal of Medicinal Chemistry

Volumn 33, Issue 10, 1990, Pages 2899-2905

  Yardley, John P ^a   Morris Husbands, G E ^a   Stack, Gary ^a   Butch, Jacqueline ^a   Bicksler, James ^a   Moyer, John A ^a   Muth, Eric A ^a   Andree, Terrance ^a   Fletcher, Horace ^a   James, Michael N G ^b   Sielecki, Anita R ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 [1 (3,4 DICHLOROPHENYL) 2 (DIMETHYLAMINO)ETHYL]CYCLOHEXANOL; DESIPRAMINE; IMIPRAMINE; NORADRENALIN; PHENETHYLAMINE DERIVATIVE; UNCLASSIFIED DRUG; VENLAFAXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL MODEL; CORTICOTROPIN RELEASE; CRYSTALLOGRAPHY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SYNTHESIS; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE;

EID: 0024989846     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00172a035     Document Type: Article

References (33)

1. Feighner, J. P. J. Clin. Psychiatry 1983, 44, 49.
2. Mobley, P. L.; Sulser, F. in Antidepressants: Neurochemical, Behavioral and Clinical Perspectives; Enna, S. J., Malick, J. B., Richelson, E., Eds.; Raven Press: New York, 1981; pp 31–51.
3. Yardley, J. P.; Fletcher, H., III; Russell, P. B. Experientia 1970, 34, 1124.
4. Hesp, B.; Resch, J. In Psychopharmacology; Meltzer, H. Y., Ed.; Raven Press: New York, 1987; pp 1637–1647.
5. Gswend, H. W. In Neuroleptics; Fielding, S., Lai, H., Eds.; Futura Publishing Co.: Mount Kisco, NY, 1974; p 29.
6. Finch, N. In Antidepressants; Fielding, S., LaI, H., Eds.; Futura Publishing Co.: Mount Kisco, NY, 1975; p 30.
7. Sauvetre, R.; Roux-Schmitt, M.-C.; Seyden-Penne, J. Tetrahedron 1978, 34, 2135.
8. Husbands, G. E. M.; Yardley, J. P.; Muth, E. A. U.S. Pat. 4,611, 078, 1986.
9. Freifelder, M. J. Am. Chem. Soc. 1960, 82, 2386.
10. Tilford, C. H.; Van Campen, M. G., Jr. J. Am. Chem. Soc. 1954, 76, 2431.
11. Yoon, N. M.; Brown, H. C. J. Am. Chem. Soc. 1968, 90, 2927.
12. Brown, H. C.; Heim, P. J. Am. Chem. Soc. 1964, 86, 3566.
13. Djuric, S.; Venit, J.; Magnus, P. Tetrahedron Lett. 1981, 22, 1787.
14. Raisman, R.; Briley, M. S.; Langer, S. Z. Eur. J. Pharmacol. 1980, 61, 373.
15. Langer, S. Z.; Moret, C.; Raisman, R.; Dubocovich, M. L.; Briley, M. Science 1980, 210, 1133.
16. Sette, M.; Briley, M. S.; Langer, S. Z. J. Neurochem. 1980, 40, 622.
17. Askew, B. M. Life Sci. 1963, 2, 725.
18. Reilly, M. A.; Sigg, E. B. J. Pharmacol. Exp. Ther. 1982,222, 583.
19. Weiss, B.; Heydorn, W.; Frazer, A. In Typical and Atypical Antidepressants: Molecular Mechanisms; Costa, E., Racagni, G., Eds.; Raven Press: New York, 1982; pp 37–53.
20. Muth, E. A.; Moyer, J. A.; Nielsen, S. T.; Sigg, E. B. Soc. Neurosci. 1984, 261.
21. Moyer, J. A.; Muth, E. A.; Haskins, J. T.; Lappe, R. W.; Sigg, E. B. Soc. Neurosci. 1984, 261.
22. Ames, B. N.; McCann, J.; Yamasaki, E. Mutagen. Res. 1975, 31, 374.
23. Muth, E. A.; Haskins, J. T.; Moyer, J. A.; Husbands, G. E. M.; Nielsen, S. T.; Sigg, E. B. Biochem. Pharmacol. 1986,35, 4493.
24. Sulser, F.; Vetulani, J.; Moldey, P. L. Biochem. Pharmacol. 1978, 27, 257.
25. Peroutka, S. J.; Snyder, S. H. Science 1980, 210, 88.
26. North, A. C. T.; Phillips, D. C.; Mathews, F. S. Acta Crystal. logr. 1968, A24, 351.
27. Stewart, J. M.; Kundell, F. A.; Baldwin, J. C. The XRAY70 System; University of Maryland, College Park, MD, 1970.
28. Cromer, D. T.; Mann, J. B. Acta Crystallogr. 1968, A24, 321.
29. Mason, R.; Robertson, G. B., Adv. Struct. Res. Diffr. Methods 1966, 2, 57.
30. Hamilton, W. C. Acta Crystallogr. 1967, 18, 321.
31. Bennett, J. P. In Neurotransmitter Receptor Binding; Yamamura, H. I., Enna, S., Kuhar, M. J., Eds.; Raven Press: New York, 1978; pp 57–90.
32. Wood, M. D.; Wyllie, M. G. J. Neurochem. 1981, 37, 795.
33. Steiner, A. L.; Parker, C. W.; Kipnis, D. M. J. Biol. Chem. 1972, 247, 1106.